<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title>Molecular Vision</journal-title><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">168</article-id><article-id pub-id-type="publisher-id">2007MOLVIS339</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Joint effects of polymorphisms in the <italic>HTRA1, LOC387715/ARMS2</italic>, and <italic>CFH</italic> genes on AMD in a Caucasian population</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Francis</surname><given-names>Peter J</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Hong</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>DeWan</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Hoh</surname><given-names>Josephine</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Klein</surname><given-names>Michael L</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label>1</label>Macular Degeneration Center, Casey Eye Institute, Oregon Health &#x00026; Science University, Portland, OR</aff><aff id="aff2"><label>2</label>Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven CT</aff></contrib-group><author-notes><fn><p>The first two authors contributed equally to this work.</p></fn><corresp id="cor1">Correspondence to: Josephine Hoh, Ph.D. Department of Epidemiology and Public Health Yale University 60 College Street, Room 416 New Haven CT 06520; Phone: (203) 785-6831; FAX: (203) 785-6279; email: <ext-link ext-link-type="uri" xlink:href="mailto:josephine.hoh@yale.edu">josephine.hoh@yale.edu</ext-link></corresp></author-notes><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>04</day><month>8</month><year>2008</year></pub-date><volume>14</volume><fpage>1395</fpage><lpage>1400</lpage><history><date date-type="received"><day>26</day><month>10</month><year>2007</year></date><date date-type="accepted"><day>20</day><month>6</month><year>2008</year></date></history><permissions><copyright-year>2008</copyright-year><copyright-holder>Molecular Vision</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title>Purpose</title><p>To estimate the joint effects of single nucleotide polymorphysms (SNPs) in the genes <italic>complement factor H</italic> (<italic>CFH)</italic>, <italic>HtrA serine peptidase 1</italic> (<italic>HTRA1),</italic> and <italic>age-related maculopathy susceptibility 2</italic> (<italic>LOC387715/ARMS2)</italic> in a Caucasian age related macular degeneration (AMD) case-control cohort.</p></sec><sec sec-type="methods"><title>Methods</title><p>We genotyped three SNPs, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link> (exon 9, <italic>CFH</italic>), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link> (<italic>HTRA1</italic> promoter, &#x02212;512 bp), and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link> (6.6 kb upstream of <italic>HTRA1</italic> in <italic>LOC387715/ARMS2</italic>) in 333 cases with advanced AMD (choroidal neovascularization [CNV] and geographic atrophy) and 171 age-matched examined controls. Association tests were performed for individual SNPs and jointly with the <italic>CFH</italic> SNP Y402H. Analyses for interaction were also performed.</p></sec><sec><title>Results</title><p>The linkage disequilibrium measure for two SNPs on 10q26, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link>, is D'=0.8 and all four possible haplotypes of the two SNPs were detected in the samples. The allelic association test for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link> on the promoter of <italic>HTRA1</italic> yielded p-values less than 10<sup>&#x02212;10</sup> for geographic atrophy, less than 10<sup>&#x02212;16</sup> for neovascularization, and less than 10<sup>&#x02212;19</sup> for the pooled phenotypes (with an odds ration [OR] of 3.973; 95% confidence interval [CI] 2.928, 5.390). Disease risk is conferred in a dosage-dependent fashion. Similar figures were observed for the <italic>LOC387715/ARMS2</italic> SNP. No interaction was detected between either between the 10q26 SNPs or the <italic>CFH</italic> SNP.</p></sec><sec><title>Conclusions</title><p>This is the first analysis to show that the two 10q26 SNPs are not in complete linkage disequilibrium. Our studies however show that both the <italic>HTRA1</italic> and <italic>LOC387715/ARMS2</italic> SNP appear to contribute equally to disease risk (both geographic atrophy and choroidal neovascularization) with no evidence of interaction with <italic>CFH.</italic></p></sec></abstract><custom-meta-wrap><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Last eX pass/corrections</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Several genes have now been associated with the development of age-related macular degeneration (AMD). The most consistently identified genetic variants lie within the regulators of complement activation (RCA) locus on chromosome 1, principally the gene <italic>complement factor H</italic> (<italic>CFH)</italic> [<xref ref-type="bibr" rid="r1">1</xref>-<xref ref-type="bibr" rid="r3">3</xref>], and the 10q26 chromosomal region [<xref ref-type="bibr" rid="r4">4</xref>-<xref ref-type="bibr" rid="r6">6</xref>]. Association analyses of this latter locus initially implicated the single nucleotide polymorphism (SNP) <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link>, located in the coding sequence of a gene now known as <italic>age-related maculopathy susceptibility 2</italic> (ARMS2) [<xref ref-type="bibr" rid="r4">4</xref>-<xref ref-type="bibr" rid="r6">6</xref>], to be the variant most likely associated with AMD. Subsequent rigorous sequencing of the region revealed a polymorphism, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link>, in the promoter of the adjacent gene, <italic>HtrA serine peptidase 1</italic> (<italic>HTRA1)</italic>, some 7 kb downstream of <italic>LOC387715/ARMS2</italic>, to be also associated with advanced AMD [<xref ref-type="bibr" rid="r7">7</xref>,<xref ref-type="bibr" rid="r8">8</xref>]. To date, this finding has been corroborated in two other Caucasian [<xref ref-type="bibr" rid="r9">9</xref>,<xref ref-type="bibr" rid="r10">10</xref>] one central European [<xref ref-type="bibr" rid="r11">11</xref>], and one Japanese [<xref ref-type="bibr" rid="r12">12</xref>] populations.</p><p>Intriguingly, both <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link> are in almost complete linkage disequilibrium in all cohorts examined thus far (D' &#x0003e;0.98) [<xref ref-type="bibr" rid="r7">7</xref>,<xref ref-type="bibr" rid="r12">12</xref>,<xref ref-type="bibr" rid="r13">13</xref>], limiting the ability of genetic association analyses to resolve the functional variant. Initial molecular biologic analyses suggest that the promoter SNP in <italic>HTRA1</italic>, a gene that encodes a heat shock serine protease found in retinal tissues, produces a change in the expression level of the gene [<xref ref-type="bibr" rid="r7">7</xref>,<xref ref-type="bibr" rid="r8">8</xref>]. Interestingly, HTRA1 expression has been reported to increase with age [<xref ref-type="bibr" rid="r14">14</xref>].</p><p>Most recently, <italic>LOC387715/ARMS2</italic> has been suggested to encode a mitochondrial-associated protein that is also found in the retina. The polymorphism which results in the substitution of serine-for-alanine at position 69 may result in misfolding of the protein [<xref ref-type="bibr" rid="r15">15</xref>].</p><p>In this article, we present further analyses of the 10q26 polymorphisms in a Caucasian population from the USA with advanced AMD (both geographic atrophy and choroidal neovascularization) and assess joint effects of the <italic>HTRA1</italic><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link> SNP, the <italic>LOC387715/ARMS2</italic> SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link> (A69S), and the <italic>CFH</italic> SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link> (Y402H).</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Phenotyping</title><p>Sporadic advanced cases (average age 79 years of age, range 60 to 100 years of age) and controls (average age 74, range 63 to 92 years of age, <xref ref-type="table" rid="t1">Table 1</xref>) of Northern European Caucasian descent were ascertained from the clinical practices of P.F. and M.K. Diagnosis of AMD in was based upon the presence of geographic atrophy or choroidal neovascularization (CNV; equivalent to Age-Related Eye Disease Study [AREDS] category 4) [<xref ref-type="bibr" rid="r16">16</xref>]. Control subjects were at least 60 years of age, with no signs of AMD (defined as no drusen larger than 63 &#x003bc;m in diameter; equivalent to AREDS category 1).</p><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>Summary of age distributions for the four phenotypic groups</title></caption><table frame="hsides" rules="groups"><col width="71" span="1"/><col width="71" span="1"/><col width="71" span="1"/><col width="71" span="1"/><col width="71" span="1"/><col width="71" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Phenotype</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Sample size</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Min</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>1st quantile</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Mean</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Max</bold></th></tr></thead><tbody><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Control<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">171<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">58<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">68<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">73<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">92<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Dry<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">108<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">48<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">75<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">79<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">95<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Dry+Wet<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">69<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">74<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">79<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">91<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Wet</td><td valign="top" align="center" rowspan="1" colspan="1">205</td><td valign="top" align="center" rowspan="1" colspan="1">40</td><td valign="top" align="center" rowspan="1" colspan="1">74</td><td valign="top" align="center" rowspan="1" colspan="1">78</td><td valign="top" align="center" rowspan="1" colspan="1">100</td></tr></tbody></table><table-wrap-foot><p>Counts, Hardy-Weinberg equilibrium tests, allele frequencies, genotypic association tests for three risk SNPs in each and combined cohorts.</p></table-wrap-foot></table-wrap><p>One hundred and eight patients with geographic atrophy (GA) together with 205 patients with CNV, 20 with both GA and CNV, and 171 age-matched examined controls were ascertained. Informed consent was obtained from all participants, and the procedures used conformed to the tenets of the Declaration of Helsinki.</p></sec><sec><title>Genotyping</title><p>Genotyping of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link> was performed as described previously [<xref ref-type="bibr" rid="r17">17</xref>]. Specifically, PCR was performed using primers designed to amplify the genomic region containing each SNP (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link> forward: 5&#x02032;-GGT GGT TCC TGT GTC CTT CA-3&#x02032;, reverse: 5&#x02032;-GGG GTA AGG CCT GAT CAT CT-3&#x02032;; <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link> forward: 5&#x02032;-CGG ATG CAC CAA AGA TTC TCC-3&#x02032;, reverse: 5&#x02032;-TTC GCG TCC TTC AAA CTA ATG G-3&#x02032;). Following amplification, genotype determination was performed on the PCR products using either temperature gradient capillary electrophoresis (TGCE; REVEAL; SpectruMedix, State College, PA) or through direct sequencing using CEQ2000XL DNA analysis system (Beckman Coulter, Fullerton, CA).</p></sec><sec><title>Statistical analyses</title><p>Hardy&#x02013;Weinberg Equilibrium (HWE) &#x003c7;<sup>2</sup> values in the entire sample and controls alone were calculated to identify possible genotyping errors. No extreme deviations (i.e., &#x003c7;<sup>2</sup> &#x0003e; 50) were observed (<xref ref-type="table" rid="t2">Table 2</xref>). Linkage disequilibrium (LD) was measured by the D' value. For each SNP, Pearson&#x02019;s &#x003c7;<sup>2</sup> tests with one degree of freedom for association were performed. Odds ratios (OR) and their respective confidence intervals were calculated, [<xref ref-type="bibr" rid="r18">18</xref>]. Both SNPHAP and PHASE were used to estimate the haplotype frequencies and to reconstruct the diplotype (haplotype pair) for each sample. Consistent results obtained by using both algorithms were taken for further regression analyses.</p><table-wrap id="t2" position="float"><label>Table 2</label><caption><title>Genotyping information and Fisher&#x02019;s exact tests for association between SNPs and disease status</title></caption><table frame="hsides" rules="groups"><col width="95" span="1"/><col width="117" span="1"/><col width="108" span="1"/><col width="99" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>SNP</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link>&#x02028;<bold>(<italic>HTRA1 promoter SNP</italic>)</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link>&#x02028;<bold>(<italic>LOC387715/ARMS2</italic>)</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link>&#x02028;<bold>(<italic>CFH</italic>)</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">HWE &#x003c7;<sup>2</sup><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">5.37<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.702<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.116<hr/></td></tr><tr><td colspan="4" valign="top" align="center" scope="col" rowspan="1">Genotypic /Allelic test<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">GA<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">2.05e-8/ 6.94e-11<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">2.36e-9 / 9.83e-12<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.14e-6 / 4.80e-7<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">GA+CNV<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">7.86e-7 / 1.33e-8<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">3.97e-7 / 1.92e-8<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">3.98e-3 / 1.31e-3<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">CNV<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">9.82e-15 / 1.67e-17<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">6.39e-16 / 2.42e-17<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">9.60e-6 / 1.96e-6<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Pooled cases<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">2.70e-17 / 7.55e-21<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">3.12e-17 / 1.10e-19<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">4.78e-8 / 1.52e-8<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Odd Ratio (95% CI)</td><td valign="top" align="left" rowspan="1" colspan="1">3.973 (2.928, 5.390)</td><td valign="top" align="left" rowspan="1" colspan="1">4.671 (3.245, 6.722)</td><td valign="top" align="left" rowspan="1" colspan="1">2.399 (1.768, 3.256)</td></tr></tbody></table><table-wrap-foot><p>Genotyping data confirming Hardy-Weinberg equilibrium for all SNPs analyzed. Fisher&#x02019;s exact tests shows strong association between SNPs and advanced AMD disease status. Abbreviations: HWE=Hardy&#x02013;Weinberg Equilibrium. Fisher&#x02019;s exact genotypic / allelic association test for various disease status: p-value. GA=geographic atrophy, CNV=choroidal neovascularization, GA+CNV refers to those individuals with GA and CNV in one or both eyes.</p></table-wrap-foot></table-wrap><p>Joint ORs for two SNPs (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link> and complement factor H (<italic>CFH</italic>) Y402H, previously genotyped) were calculated using standard methods [<xref ref-type="bibr" rid="r19">19</xref>]. Marginal ORs and their confidence intervals for the two SNPs were calculated using logistic regression with SNPs <italic>CFH</italic> Y402H and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link> as independent variables [<xref ref-type="bibr" rid="r19">19</xref>]. The standard logistic regression models for marginal and joint effect (effect of marker X<sub>i</sub> controlled for marker X<sub>j</sub>) are formulated as logit(p)=&#x003b2;<sub>0</sub> + &#x003b2;<sub>1</sub>X<sub>1</sub> and logit(p)=&#x003b2;<sub>0</sub> + &#x003b2;<sub>1</sub>X<sub>1</sub> + &#x003b2;<sub>2</sub>X<sub>2</sub>, respectively. For highly correlated SNPs (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link>), an interaction term was incorporated in the model: logit(p)=&#x003b2;<sub>0</sub> + &#x003b2;<sub>1</sub>X<sub>1</sub> + &#x003b2;<sub>2</sub>X<sub>2</sub> + &#x003b2;<sub>3</sub>X<sub>1</sub>&#x000d7;X<sub>2</sub>.</p><p>To assess the statistical significance of the effect, the likelihood ratio test is performed. To control for confounding, the Mantel-Hanzel (M-H) test for association with two variables was used [<xref ref-type="bibr" rid="r19">19</xref>]. Four genotypic models were considered (Full, Recessive, Multiplicative, and Dominant) and the conventional Aikake information criterion (AIC) [<xref ref-type="bibr" rid="r20">20</xref>] was used to assess the fit of each model.</p></sec></sec><sec sec-type="results"><title>Results</title><p>In our US Caucasian case-control cohort, the <italic>HTRA1</italic><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link> SNP showed strong disease association with both advanced forms of AMD, p&#x0003c;10<sup>&#x02212;10</sup> (geographic atrophy), p&#x0003c;10<sup>&#x02212;16</sup> (neovascularization), and p&#x0003c;10<sup>&#x02212;20</sup> for pooled phenotypes. The <italic>LOC387715/ARMS2</italic><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link> SNP showed similar levels of association. Strong association is also confirmed between disease status and the <italic>CFH</italic> SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link> (<xref ref-type="table" rid="t2">Table 2</xref>).</p><p>The two 10q26 SNPs, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link>, were also in strong linkage disequilibrium (D'=0.80), though not in complete LD as all possible diplotypes were found in the population. <xref ref-type="table" rid="t3">Table 3</xref> shows how the four potential haplotypes produced by the two SNPs were distributed; AMD cases were approximately three times more likely to have the high risk haplotype <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link> &#x02018;T&#x02019; + <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link> &#x02018;A&#x02019; than controls.</p><table-wrap id="t3" position="float"><label>Table 3</label><caption><title>Haplotype frequencies with estimated standard deviations in parentheses</title></caption><table frame="hsides" rules="groups"><col width="90" span="1"/><col width="54" span="1"/><col width="45" span="1"/><col width="54" span="1"/><thead><tr><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1"><bold>Haplotype (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link> + <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link>)</bold></th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1"><bold>Pooled sample</bold></th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1"><bold>Case</bold></th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1"><bold>Control</bold></th></tr></thead><tbody><tr><td valign="bottom" align="center" scope="row" rowspan="1" colspan="1">GG</td><td valign="bottom" align="center" rowspan="1" colspan="1">0.412 (0.006)</td><td valign="bottom" align="center" rowspan="1" colspan="1">0.277 (0.006)</td><td valign="bottom" align="center" rowspan="1" colspan="1">0.679 (0.014)</td></tr><tr><td valign="bottom" align="center" scope="row" rowspan="1" colspan="1">GA</td><td valign="bottom" align="center" rowspan="1" colspan="1">0.190 (0.005)</td><td valign="bottom" align="center" rowspan="1" colspan="1">0.229 (0.006)</td><td valign="bottom" align="center" rowspan="1" colspan="1">0.114 (0.006)</td></tr><tr><td valign="bottom" align="center" scope="row" rowspan="1" colspan="1">TG</td><td valign="bottom" align="center" rowspan="1" colspan="1">0.124 (0.007)</td><td valign="bottom" align="center" rowspan="1" colspan="1">0.143 (0.006)</td><td valign="bottom" align="center" rowspan="1" colspan="1">0.087 (0.014)</td></tr><tr><td valign="bottom" align="center" scope="row" rowspan="1" colspan="1">TA</td><td valign="bottom" align="center" rowspan="1" colspan="1">0.273 (0.005)</td><td valign="bottom" align="center" rowspan="1" colspan="1">0.351 (0.007)</td><td valign="bottom" align="center" rowspan="1" colspan="1">0.119 (0.005)</td></tr></tbody></table><table-wrap-foot><p>Haplotype frequencies for the <italic>LOC387715</italic> and <italic>HTRA1</italic> SNPs (with estimated standard deviations in parentheses) showing the presence of all four potential haplotypes in the cohort. P-value for independence between haplotypes and disease: 1.1e-22.</p></table-wrap-foot></table-wrap><p><xref ref-type="table" rid="t4">Table 4</xref> shows joint and marginal odds ratios for the <italic>HTRA1</italic> and <italic>CFH</italic> SNPs. Odds ratios of having the disease rise to almost 200 in individuals who are homozygous for the risk alleles in both genes. Similar odds ratios are observed for the <italic>LOC387715/ARMS2</italic> and <italic>CFH</italic> SNP (<xref ref-type="table" rid="t5">Table 5</xref>). When joint odds ratios were computed for the two highly correlated SNPs on 10q26 and the interaction terms considered in the regression model, the resulting confidence interval encompasses 0 and &#x0221e; due to insufficient sample size in each cell (<xref ref-type="table" rid="t6">Table 6</xref>).</p><table-wrap id="t4" position="float"><label>Table 4</label><caption><title>Joint and marginal odds ratios (pooled cases) for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link></title></caption><table frame="hsides" rules="groups"><col width="131" span="1"/><col width="31" span="1"/><col width="76" span="1"/><col width="63" span="1"/><col width="125" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link></th><th colspan="3" valign="top" align="left" scope="colgroup" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link>&#x02028;<bold> risk (adjusted for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link>)</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">GG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.53<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.92<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">GA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.45<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11.69<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">25.98<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.30 (95% CI: 2.50, 7.39)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">AA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.33<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">15.55<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">192.71<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">8.13 (95% CI: 3.70, 17.87)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link>&#x02028; risk (adjusted for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link>)</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">3.17 (95% CI: 1.77, 5.66)</td><td valign="top" align="center" rowspan="1" colspan="1">5.74 (95% CI: 2.75, 11.98)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p>Marginal odds ratios are calculated based on a logistic regression model by assuming an additive effect of two SNPs after a logit transformation on odds ratio</p></table-wrap-foot></table-wrap><table-wrap id="t5" position="float"><label>Table 5</label><caption><title>Joint and marginal odds ratios (pooled cases) for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link></title></caption><table frame="hsides" rules="groups"><col width="95" span="1"/><col width="45" span="1"/><col width="81" span="1"/><col width="135" span="1"/><col width="72" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link><hr/></th><th colspan="3" valign="top" align="left" scope="colgroup" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link>&#x02028;<bold> risk (adjusted for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link>)</bold><hr/></th></tr></thead><tbody><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">TT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">GG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.59<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.38<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">GT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.72<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">13.66<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">36.52<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.24 (95% CI: 3.08, 8.91)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">TT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.63<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">38.77<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">227.57<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">15.30 (95% CI: 5.75,40.73)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link>&#x02028; risk (adjusted for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link>)</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">3.32 (95% CI: 1.87, 5.91)</td><td valign="top" align="center" rowspan="1" colspan="1">6.12 (95% CI: 2.92, 12.85)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p>Marginal odds ratios are calculated based on a logistic regression model by assuming an additive effect of two SNPs after a logit transformation on odds ratio.</p></table-wrap-foot></table-wrap><table-wrap id="t6" position="float"><label>Table 6</label><caption><title>Joint genotype counts in cases/controls for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link></title></caption><table frame="hsides" rules="groups"><col width="112" span="1"/><col width="112" span="1"/><col width="108" span="1"/><col width="108" span="1"/><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td colspan="3" valign="top" align="left" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link><hr/></td></tr><tr><td rowspan="3" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link></td><td valign="top" align="center" rowspan="1" colspan="1">77/74<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">39453<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0/0<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">0/5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">27/117<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">39549<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">0/2</td><td valign="top" align="center" rowspan="1" colspan="1">0/5</td><td valign="top" align="center" rowspan="1" colspan="1">24959</td></tr></tbody></table><table-wrap-foot><p>Joint genotype counts of controls/cases, sample size too small to fit regression model with interaction terms.</p></table-wrap-foot></table-wrap><p>Haplotype analyses of these two closely located SNPs were therefore employed using SNPHAP and PHASE programs (<xref ref-type="table" rid="t7">Table 7</xref>). Under the regression framework, no interaction was detected between the 10q26 haplotypes and the <italic>CFH</italic> SNP (<xref ref-type="table" rid="t8">Table 8</xref>). After dropping the interaction term the effect of one controlled for the other can be estimated and tested for significance based on the likelihood ratio test (<xref ref-type="table" rid="t9">Table 9</xref>). Estimated haplotype frequencies, diplotype counts, odds ratio, and p-values for testing independ for all observed diplotypes are provided in <xref ref-type="table" rid="t10">Table 10</xref>.</p><table-wrap id="t7" position="float"><label>Table 7</label><caption><title>Tests for model fit of the effects in <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link></title></caption><table frame="hsides" rules="groups"><col width="75" span="1"/><col width="70" span="1"/><col width="69" span="1"/><col width="69" span="1"/><col width="65" span="1"/><col width="67" span="1"/><col width="38" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1"><bold>Model for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link></bold>&#x02028;<bold>x <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link></bold><hr/></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><bold>PAR % (95% CI)</bold></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><bold>M-H test: p-value</bold></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>LRT:</bold>&#x02028;<bold>p-value</bold><hr/></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>AIC</bold>&#x02028;<bold>value</bold><hr/></th></tr></thead><tbody><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Full<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">58.0&#x02028;(46.4, 67.0)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">62.8&#x02028;(45.5, 74.4)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.24e-11<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.07e-6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.20e-2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">398.3<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rec x Rec<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">21.6&#x02028;(13.9, 28.7)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20.1&#x02028;(10.2, 28.9)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.08e-4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.20e-3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.12e-2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">439.5<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rec x Mul<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">21.7&#x02028;(14.4, 28.7)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">75.7&#x02028;(63.3, 83.8)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.05e-4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.11e-6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.62e-1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">425.6<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rec x Dom<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">22.3&#x02028;(14.4, 29.4)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">60.4&#x02028;(43.1, 73.6)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.73e-5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.38e-6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.28e-1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">428.6<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mul x Rec<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">67.2&#x02028;(59.1, 74.0)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">19.8&#x02028;(8.8, 28.5)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.11e-11<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.06e-3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.15e-2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">411.7<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mul x Mul<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">67.4&#x02028;(60.1, 73.9)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">76.1 (64.9,84.1)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.24e-11<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.07e-6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.45e-1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">397.5<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mul x Dom<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">67.7&#x02028;(59.8, 74.2)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">62.0&#x02028;(45.0, 74.9)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.03e-11<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.83e-6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.45e-1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">399.3<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Dom x Rec<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">56.9&#x02028;(45.2, 66.2)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20.7&#x02028;(10.3, 29.2)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.63e-11<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.71e-3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.77e-2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">412.5<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Dom x Mul<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57.5&#x02028;(47.1, 66.0)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">76.7&#x02028;(66.1, 84.3)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.51e-11<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.06e-6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.47e-1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">397.8<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Dom x Doc</td><td valign="top" align="center" rowspan="1" colspan="1">58.2&#x02028;(47.4, 67.3)</td><td valign="top" align="center" rowspan="1" colspan="1">62.9&#x02028;(45.7, 74.9)</td><td valign="top" align="center" rowspan="1" colspan="1">6.88e-12</td><td valign="top" align="center" rowspan="1" colspan="1">1.80e-6</td><td valign="top" align="center" rowspan="1" colspan="1">9.51e-1</td><td valign="top" align="center" rowspan="1" colspan="1">400.6</td></tr></tbody></table><table-wrap-foot><p>Models for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link>&#x000a0;&#x000d7;&#x000a0;<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link>. Note: According to AIC value, Mul x Mul model fits the data best. Similar results for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link>&#x000a0;&#x000d7;&#x000a0;<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link>.</p></table-wrap-foot></table-wrap><table-wrap id="t8" position="float"><label>Table 8</label><caption><title>Joint analyses of the CFH SNP and 10q26 haplotypes</title></caption><table frame="hsides" rules="groups"><col width="134" span="1"/><col width="41" span="1"/><col width="63" span="1"/><col width="72" span="1"/><col width="130" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link>&#x02028;<bold> + <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link></bold></th><th colspan="3" valign="top" align="left" scope="colgroup" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link>&#x02028;<bold> + <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link> risk (adjusted for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link>)</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">GG/GG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.09<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.48<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Non GG/GG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.44<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">14.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">26.86<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.49 (95% CI: 4.01, 10.50)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1061170">rs1061170</ext-link>&#x02028; risk (adjusted for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link> + <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link>)</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">2.34 (95% CI: 1.34, 4.08)</td><td valign="top" align="center" rowspan="1" colspan="1">4.90 (95% CI: 2.40, 10.00)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p>The haplotype information for 10q26 gene is estimated using software PHASE. By treating the haplotype GG (formed by high risk alleles G and G at <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link>) as a new &#x0201c;allele&#x0201d;, we studied the joint and main effects of CFH SNP-10q26 haplotypes as in <xref ref-type="table" rid="t3">Table 3</xref>. Here a recessive mode of inheritance for 10q26 gene is assumed so that the gentotypes are classified to GG/GG and non GG/GG.</p></table-wrap-foot></table-wrap><table-wrap id="t9" position="float"><label>Table 9</label><caption><title>Estimated frequencies and their standard deviations of haplotypes for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link></title></caption><table frame="hsides" rules="groups"><col width="122" span="1"/><col width="90" span="1"/><col width="90" span="1"/><col width="107" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Haplotype (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link> +<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link>)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Pooled sample</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Case</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Control</bold></th></tr></thead><tbody><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">GG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.412 (0.006)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.277 (0.006)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.679 (0.014)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">GA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.190 (0.005)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.229 (0.006)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.114 (0.006)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">TG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.124 (0.007)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.143 (0.006)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.087 (0.014)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">TA</td><td valign="top" align="center" rowspan="1" colspan="1">0.273 (0.005)</td><td valign="top" align="center" rowspan="1" colspan="1">0.351 (0.007)</td><td valign="top" align="center" rowspan="1" colspan="1">0.119 (0.005)</td></tr></tbody></table><table-wrap-foot><p>Presented in parentheses are estimated standard deviations. All the results were obtained by software SNPHAP using joint genotypes of SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link>.</p></table-wrap-foot></table-wrap><table-wrap id="t10" position="float"><label>Table 10</label><caption><title>Counts, odds ratio, and p-value for testing independence for all observed diplotypes (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link> x <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link>)</title></caption><table frame="hsides" rules="groups"><col width="63" span="1"/><col width="51" span="1"/><col width="50" span="1"/><col width="50" span="1"/><col width="48" span="1"/><col width="80" span="1"/><col width="81" span="1"/><col width="89" span="1"/><col width="47" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"/><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>GG/GG</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>GG/GA</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>GG/TG</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>TG/TG</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>GG/TA</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>GA/TA</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>TG/TA</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>TA/TA</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Case<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">134<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">33<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Control<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">89<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">37<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">139<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">73<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">13<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Odds ratio<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">---<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">---<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">---<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.06 (95% CI: 2.45,10.45)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.34 (95% CI: 3.99,10.09)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">21.98(95% CI: 8.54,56.55)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">---<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">P-value</td><td valign="top" align="center" rowspan="1" colspan="1">---</td><td valign="top" align="center" rowspan="1" colspan="1">0.02</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td><td valign="top" align="center" rowspan="1" colspan="1">0.16</td><td valign="top" align="center" rowspan="1" colspan="1">2.62e-6</td><td valign="top" align="center" rowspan="1" colspan="1">1.51e-16</td><td valign="top" align="center" rowspan="1" colspan="1">2.41e-18</td><td valign="top" align="center" rowspan="1" colspan="1">1.16e-5</td></tr></tbody></table><table-wrap-foot><p>Odds ratios and their CIs are based on logistic regression models. Where counts are less than 6, ORs are ignored; p-values are for Fisher&#x02019;s exact tests. The phase-known diplotypes and estimated diplotypes were pooled, which were sufficient for haplotype analyses. P-value for testing independence of disease and all diplotypes is 4.76e-24.</p></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>Our data confirm the association between advanced AMD (both geographic atrophy and CNV) and the 10q26 SNPs <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link> (<italic>HTRA1</italic> promoter) and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10490924">rs10490924</ext-link> (<italic>LOC387715/ARMS2</italic> A69S), independent of the <italic>CFH</italic> Y402H polymorphism. In all previous papers which examined linkage disequilibrium in the 10q26 region, these two SNPs have been reported to be in almost complete linkage disequilibrium [<xref ref-type="bibr" rid="r7">7</xref>,<xref ref-type="bibr" rid="r13">13</xref>]. This was not the case in our population where the D' between the SNPs was 0.80. This is a critical finding as it does indicate that other studies using larger populations may be able to determine which of the two 10q26 SNPs may be contributing most to disease status. The number of individuals in our study was too small to permit this. Odds ratios of having advanced AMD, when adjusted for the <italic>CFH</italic> SNP, were not significantly different for either of the 10q26 SNPs genotyped in our cohort. Each of the two SNPs also confers similar odd ratios when combined with the <italic>CFH</italic> SNP. Neither SNP was more clearly associated with disease status nor with advanced AMD phenotype though arguably if our cohort is enlarged substantially it might be possible to distinguish which SNP contribute the most risk.</p><p>Previous studies [<xref ref-type="bibr" rid="r21">21</xref>] have not identified gene-locus interaction between <italic>CFH</italic> and the region on chromosome 10q26. Our analyses are in agreement with this. Thus it seems likely that <italic>CFH</italic> and 10q26 contribute independently to AMD development, at least at the genomic level.</p><p>There remains an enormous amount to be learned about the genetic etiology of AMD. Nonetheless, there is little question that either <italic>HTRA1</italic> and/or <italic>LOC387715/ARMS2</italic> or a 10q26 haplotype that expands more than two SNPs play a crucial role in determining the advanced AMD phenotypes. Functional consequences from the polymorphisms of <italic>LOC387715/ARMS2</italic> or <italic>HTRA1,</italic> or even <italic>CFH,</italic> have yet to be determined. Our current data indicate that in a Caucasian population from the USA, the <italic>HTRA1</italic> promoter SNP is strongly associated with advanced AMD but appears to exert its effect independently of <italic>CFH</italic>.</p></sec></body><back><ack><title>Acknowledgements:</title><p>This work is supported by grants from the National Institutes of Health (NIH) National Eye Institute R01-EY12203 (Dr. Klein) R01-EY015771 and R21-EY018127 (J.H.); the Foundation Fighting Blindness, Owing Mills, MD (P.J.F.); the Macular Degeneration Center Research Fund, Casey Eye Institute, Oregon Health &#x00026; Science University, Portland (M.L.K., P.J.F.), and Research to Prevent Blindness, New York, NY (unrestricted grant to Casey Eye Institute, Career Development Award to PJF). Verto Institute, LLC; Macular Vision Research Foundation; Ellison Foundation for Medical Research American Health Assistance Foundation (J.H.).</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>AO</given-names></name><name><surname>Ritter</surname><given-names>R</given-names><suffix>3rd</suffix></name><name><surname>Abel</surname><given-names>KJ</given-names></name><name><surname>Manning</surname><given-names>A</given-names></name><name><surname>Panhuysen</surname><given-names>C</given-names></name><name><surname>Farrer</surname><given-names>LA</given-names></name></person-group><article-title>Complement factor H polymorphism and age-related macular degeneration.</article-title><source>Science</source><year>2005</year><volume>308</volume><fpage>421</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">15761121</pub-id></citation></ref><ref id="r2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haines</surname><given-names>JL</given-names></name><name><surname>Hauser</surname><given-names>MA</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Scott</surname><given-names>WK</given-names></name><name><surname>Olson</surname><given-names>LM</given-names></name><name><surname>Gallins</surname><given-names>P</given-names></name><name><surname>Spencer</surname><given-names>KL</given-names></name><name><surname>Kwan</surname><given-names>SY</given-names></name><name><surname>Noureddine</surname><given-names>M</given-names></name><name><surname>Gilbert</surname><given-names>JR</given-names></name><name><surname>Schnetz-Boutaud</surname><given-names>N</given-names></name><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>Postel</surname><given-names>EA</given-names></name><name><surname>Pericak-Vance</surname><given-names>MA</given-names></name></person-group><article-title>Complement factor H variant increases the risk of age-related macular degeneration.</article-title><source>Science</source><year>2005</year><volume>308</volume><fpage>419</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">15761120</pub-id></citation></ref><ref id="r3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>RJ</given-names></name><name><surname>Zeiss</surname><given-names>C</given-names></name><name><surname>Chew</surname><given-names>EY</given-names></name><name><surname>Tsai</surname><given-names>JY</given-names></name><name><surname>Sackler</surname><given-names>RS</given-names></name><name><surname>Haynes</surname><given-names>C</given-names></name><name><surname>Henning</surname><given-names>AK</given-names></name><name><surname>SanGiovanni</surname><given-names>JP</given-names></name><name><surname>Mane</surname><given-names>SM</given-names></name><name><surname>Mayne</surname><given-names>ST</given-names></name><name><surname>Bracken</surname><given-names>MB</given-names></name><name><surname>Ferris</surname><given-names>FL</given-names></name><name><surname>Ott</surname><given-names>J</given-names></name><name><surname>Barnstable</surname><given-names>C</given-names></name><name><surname>Hoh</surname><given-names>J</given-names></name></person-group><article-title>Complement factor H polymorphism in age-related macular degeneration.</article-title><source>Science</source><year>2005</year><volume>308</volume><fpage>385</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15761122</pub-id></citation></ref><ref id="r4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jakobsdottir</surname><given-names>J</given-names></name><name><surname>Conley</surname><given-names>YP</given-names></name><name><surname>Weeks</surname><given-names>DE</given-names></name><name><surname>Mah</surname><given-names>TS</given-names></name><name><surname>Ferrell</surname><given-names>RE</given-names></name><name><surname>Gorin</surname><given-names>MB</given-names></name></person-group><article-title>Susceptibility genes for age-related maculopathy on chromosome 10q26.</article-title><source>Am J Hum Genet</source><year>2005</year><volume>77</volume><fpage>389</fpage><lpage>407</lpage><pub-id pub-id-type="pmid">16080115</pub-id></citation></ref><ref id="r5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Hauser</surname><given-names>MA</given-names></name><name><surname>Scott</surname><given-names>WK</given-names></name><name><surname>Postel</surname><given-names>EA</given-names></name><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>Gallins</surname><given-names>P</given-names></name><name><surname>Wong</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>YS</given-names></name><name><surname>Spencer</surname><given-names>K</given-names></name><name><surname>Schnetz-Boutaud</surname><given-names>N</given-names></name><name><surname>Haines</surname><given-names>JL</given-names></name><name><surname>Pericak-Vance</surname><given-names>MA</given-names></name></person-group><article-title>Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration.</article-title><source>Am J Hum Genet</source><year>2006</year><volume>78</volume><fpage>852</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">16642439</pub-id></citation></ref><ref id="r6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rivera</surname><given-names>A</given-names></name><name><surname>Fisher</surname><given-names>SA</given-names></name><name><surname>Fritsche</surname><given-names>LG</given-names></name><name><surname>Keilhauer</surname><given-names>CN</given-names></name><name><surname>Lichtner</surname><given-names>P</given-names></name><name><surname>Meitinger</surname><given-names>T</given-names></name><name><surname>Weber</surname><given-names>BH</given-names></name></person-group><article-title>Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk.</article-title><source>Hum Mol Genet</source><year>2005</year><volume>14</volume><fpage>3227</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">16174643</pub-id></citation></ref><ref id="r7"><label>7</label><citation citation-type="book">Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, Zhao C, Tam PO, Chan WM, Lam DS, Snyder M, Barnstable C, Pang CP, Hoh J. HTRA1 Promoter Polymorphism in Wet Age-Related Macular Degeneration. Science 2006.</citation></ref><ref id="r8"><label>8</label><citation citation-type="book">Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, Chen H, Zhao Y, Pearson E, Li X, Chien J, Dewan A, Harmon J, Bernstein PS, Shridhar V, Zabriskie NA, Hoh J, Howes K, Zhang K. A Variant of the HTRA1 Gene Increases Susceptibility to Age-Related Macular Degeneration. Science 2006.</citation></ref><ref id="r9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cameron</surname><given-names>DJ</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Gibbs</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Kaminoh</surname><given-names>Y</given-names></name><name><surname>Jorgensen</surname><given-names>A</given-names></name><name><surname>Zeng</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Brinton</surname><given-names>E</given-names></name><name><surname>Brinton</surname><given-names>G</given-names></name><name><surname>Brand</surname><given-names>JM</given-names></name><name><surname>Bernstein</surname><given-names>PS</given-names></name><name><surname>Zabriskie</surname><given-names>NA</given-names></name><name><surname>Tang</surname><given-names>S</given-names></name><name><surname>Constantine</surname><given-names>R</given-names></name><name><surname>Tong</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name></person-group><article-title>HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration.</article-title><source>Cell Cycle</source><year>2007</year><volume>6</volume><fpage>1122</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17426452</pub-id></citation></ref><ref id="r10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeAngelis</surname><given-names>MM</given-names></name><name><surname>Ji</surname><given-names>F</given-names></name><name><surname>Kim</surname><given-names>IK</given-names></name><name><surname>Adams</surname><given-names>S</given-names></name><name><surname>Capone</surname><given-names>A</given-names><suffix>Jr</suffix></name><name><surname>Ott</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>JW</given-names></name><name><surname>Dryja</surname><given-names>TP</given-names></name></person-group><article-title>Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration.</article-title><source>Arch Ophthalmol</source><year>2007</year><volume>125</volume><fpage>49</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">17210851</pub-id></citation></ref><ref id="r11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weger</surname><given-names>M</given-names></name><name><surname>Renner</surname><given-names>W</given-names></name><name><surname>Steinbrugger</surname><given-names>I</given-names></name><name><surname>K&#x000f6;fer</surname><given-names>K</given-names></name><name><surname>Wedrich</surname><given-names>A</given-names></name><name><surname>Groselj-Strele</surname><given-names>A</given-names></name><name><surname>El-Shabrawi</surname><given-names>Y</given-names></name><name><surname>Schmut</surname><given-names>O</given-names></name><name><surname>Haas</surname><given-names>A</given-names></name></person-group><article-title>Association of the HTRA1 &#x02212;625G&#x0003e;A promoter gene polymorphism with exudative age-related macular degeneration in a Central European population.</article-title><source>Mol Vis</source><year>2007</year><volume>13</volume><fpage>1274</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17679948</pub-id></citation></ref><ref id="r12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>T</given-names></name><name><surname>DeWan</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Sakamoto</surname><given-names>R</given-names></name><name><surname>Okamoto</surname><given-names>H</given-names></name><name><surname>Minami</surname><given-names>M</given-names></name><name><surname>Obazawa</surname><given-names>M</given-names></name><name><surname>Mizota</surname><given-names>A</given-names></name><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Saito</surname><given-names>Y</given-names></name><name><surname>Takagi</surname><given-names>I</given-names></name><name><surname>Hoh</surname><given-names>J</given-names></name><name><surname>Iwata</surname><given-names>T</given-names></name></person-group><article-title>HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration.</article-title><source>Mol Vis</source><year>2007</year><volume>13</volume><fpage>545</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17438519</pub-id></citation></ref><ref id="r13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Gehlbach</surname><given-names>PL</given-names></name><name><surname>Kabasawa</surname><given-names>S</given-names></name><name><surname>Kawasaki</surname><given-names>I</given-names></name><name><surname>Oosaki</surname><given-names>M</given-names></name><name><surname>Iizuka</surname><given-names>H</given-names></name><name><surname>Katayama</surname><given-names>S</given-names></name><name><surname>Awata</surname><given-names>T</given-names></name><name><surname>Yoneya</surname><given-names>S</given-names></name></person-group><article-title>Coding and noncoding variants in the CFH gene and cigarette smoking influence the risk of age-related macular degeneration in a Japanese population.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2007</year><volume>48</volume><fpage>5315</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17962488</pub-id></citation></ref><ref id="r14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grau</surname><given-names>S</given-names></name><name><surname>Richards</surname><given-names>PJ</given-names></name><name><surname>Kerr</surname><given-names>B</given-names></name><name><surname>Hughes</surname><given-names>C</given-names></name><name><surname>Caterson</surname><given-names>B</given-names></name><name><surname>Williams</surname><given-names>AS</given-names></name><name><surname>Junker</surname><given-names>U</given-names></name><name><surname>Jones</surname><given-names>SA</given-names></name><name><surname>Clausen</surname><given-names>T</given-names></name><name><surname>Ehrmann</surname><given-names>M</given-names></name></person-group><article-title>The role of human HtrA1 in arthritic disease.</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>6124</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16377621</pub-id></citation></ref><ref id="r15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kanda</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Othman</surname><given-names>M</given-names></name><name><surname>Branham</surname><given-names>KE</given-names></name><name><surname>Brooks</surname><given-names>M</given-names></name><name><surname>Khanna</surname><given-names>R</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Lyons</surname><given-names>R</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Swaroop</surname><given-names>A</given-names></name></person-group><article-title>A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration.</article-title><source>Proc Natl Acad Sci USA</source><year>2007</year><volume>104</volume><fpage>16227</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">17884985</pub-id></citation></ref><ref id="r16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><collab>The Age-Related Eye Disease Study (AREDS)</collab></person-group><article-title>design implications. AREDS report no. 1.</article-title><source>Control Clin Trials</source><year>1999</year><volume>20</volume><fpage>573</fpage><lpage>600</lpage><pub-id pub-id-type="pmid">10588299</pub-id></citation></ref><ref id="r17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okamoto</surname><given-names>H</given-names></name><name><surname>Umeda</surname><given-names>S</given-names></name><name><surname>Obazawa</surname><given-names>M</given-names></name><name><surname>Minami</surname><given-names>M</given-names></name><name><surname>Noda</surname><given-names>T</given-names></name><name><surname>Mizota</surname><given-names>A</given-names></name><name><surname>Honda</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Koyama</surname><given-names>R</given-names></name><name><surname>Takagi</surname><given-names>I</given-names></name><name><surname>Sakamoto</surname><given-names>Y</given-names></name><name><surname>Saito</surname><given-names>Y</given-names></name><name><surname>Miyake</surname><given-names>Y</given-names></name><name><surname>Iwata</surname><given-names>T</given-names></name></person-group><article-title>Complement factor H polymorphisms in Japanese population with age-related macular degeneration.</article-title><source>Mol Vis</source><year>2006</year><volume>12</volume><fpage>156</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16541016</pub-id></citation></ref><ref id="r18"><label>18</label><citation citation-type="book">Armitage P, Berry G. Statistical methods in medical research. Oxford: Blackwell Scientific Pulbications; 1971.</citation></ref><ref id="r19"><label>19</label><citation citation-type="book">Scheffe H. The analysis of variance. New York: Wiley; 1959</citation></ref><ref id="r20"><label>20</label><citation citation-type="confproc">Akaike H. Information theory and an extension of the maximum likelihood principle. In B. N. Petrov, B. F. Csaki, editors. Second International Symposium on Information Theory; 1973 p. 267&#x02013;281.</citation></ref><ref id="r21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>PJ</given-names></name><name><surname>George</surname><given-names>S</given-names></name><name><surname>Schultz</surname><given-names>DW</given-names></name><name><surname>Rosner</surname><given-names>B</given-names></name><name><surname>Hamon</surname><given-names>S</given-names></name><name><surname>Ott</surname><given-names>J</given-names></name><name><surname>Weleber</surname><given-names>RG</given-names></name><name><surname>Klein</surname><given-names>ML</given-names></name><name><surname>Seddon</surname><given-names>JM</given-names></name></person-group><article-title>The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration.</article-title><source>Hum Hered</source><year>2007</year><volume>63</volume><fpage>212</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17347568</pub-id></citation></ref></ref-list></back></article> 